Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 401–500 of 875
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
Jonjić, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00085 · Cited by 50
“The expression of NKG2D ligands makes tumors susceptible to killing by NK cells in vitro and is associated with a decreased tumor progression and a decreased capacity to form metastases in vivo (Bauer et al., 1999; Cerwenka et al., 2000, 2001; Diefenbach et al., 2000, 2001).”
BackgroundInfluentialDifferential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus
Arapović, J., Lenac, T., Antulov, R., Polić, B., Ruzsics, Z., Carayannopoulos, L., Koszinowski, U., Krmpotić, A., & Jonjić, S. (2009) · Journal of Virology · doi:10.1128/jvi.02549-08 · Cited by 49
“Since RAE-1 proteins are GPI anchored (6, 10), the logical presumption was that the luminal domain of m152 is also involved in its effect on RAE-1.”
BackgroundActivation of Natural Killer Cells: Underlying Molecular Mechanisms Revealed
Backström, E., Kristensson, K., & Ljunggren, H. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01475.x · Cited by 52
Natural killer cells in cancer immunotherapy
Wang, D., Dou, L., Sui, L., Xue, Y., & Xu, S. (2024) · MedComm · doi:10.1002/mco2.626 · Cited by 58
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies
Jia, H., Jiang, L., Shen, X., Ye, H., Li, X., Zhang, L., Hu, Y., Song, D., Jia, H., & Wang, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02397-5 · Cited by 60
“However, in CD8 + T cells, the function of NKG2D requires the simultaneous activation of TCRs [62, 63].”
Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
Gardner, G., & Fraker, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722979 · Cited by 46
Ogbomo, H., Michaelis, M., Klassert, D., Doerr, H. W., & Cinatl, J. J. (2008) · Neoplasia · doi:10.1593/neo.08972 · Cited by 45
“The NKG2D receptor is constitutively expressed on the cell surface of human NK cells [24], γδT cells, and CD8 αβT cells [25].”
BackgroundIntact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1
Champsaur, M., Beilke, J. N., Ogasawara, K., Koszinowski, U. H., Jonjić, S., & Lanier, L. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000397 · Cited by 42
Immunology and Immunotherapy in Neurosurgical Disease
Prins, R. M., & Liau, L. M. (2003) · Neurosurgery · doi:10.1227/01.neu.0000068865.34216.3a · Cited by 41
NKG2D-independent suppression of T cell proliferation by H60 and MICA
Kriegeskorte, A. K., Gebhardt, F. E., Porcellini, S., Schiemann, M., Stemberger, C., Franz, T. J., Huster, K. M., Carayannopoulos, L. N., Yokoyama, W. M., Colonna, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502026102 · Cited by 43
The Effect of Renal Ischemia-Reperfusion Injury on Expression of RAE-1 and H60 in Mice Kidney
Feng, L., Cheng, F., Ye, Z., Li, S., He, Y., Yao, X., Tang, Q., & Li, Y. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.06.013 · Cited by 39
NKG2D and Related Immunoreceptors
Strong, R. K., & McFarland, B. J. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)68008-9 · Cited by 44
“58 On macrophages, stimulation through huNKG2D triggers TNF-α production and release of nitric oxide.(59) On NK cells, stimulation through NKG2D alone is sufficient to trigger effector functions.”
BackgroundIto, A., Shimura, H., Nitahara, A., Tomiyama, K., Ito, M., Kanekura, T., Okumura, K., Yagita∥, H., & Kawai, K. (2008) · International Immunology · doi:10.1093/intimm/dxn092 · Cited by 39
Hodson, L. J., Chua, A. C. L., Evdokiou, A., Robertson, S. A., & Ingman, W. V. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.109561 · Cited by 42
Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis
Ortner, D., Tripp, C. H., Komenda, K., Dubrac, S., Zelger, B., Hermann, M., Doppler, W., Tymoszuk, P., Boon, L., Clausen, B. E., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1260215 · Cited by 41
“NKG2D-L are recognized by NKG2D present on NK cells, CD8C T cells and gd T cells.(7,29,30) The role of gd T cells in the prevention of chemical carcinogenesis is understood;(7,31) however, the possible involvement of NK cells in this process has not been investigated so far.”
BackgroundGenes of murine cytomegalovirus exist as a number of distinct genotypes
Smith, L. M., SHELLAM, G. R., & REDWOOD, A. J. (2006) · Virology · doi:10.1016/j.virol.2006.04.031 · Cited by 39
“, 1998), with sequence variation in the C57BL/6 H60 also being suggested if not explicitly stated (Diefenbach et al., 2000).”
BackgroundZhao, J., Jiang, Y., Lei, Y., Zou, K., Wang, C., Huang, S., Yi, F., & Xia, B. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06524.x · Cited by 39
Koh, C. Y., Ortaldo, J. R., Blazar, B. R., Bennett, M., & Murphy, W. J. (2003) · Blood · doi:10.1182/blood-2003-04-1367 · Cited by 38
Cellular immunity and immunotherapy of brain tumors
Robert, M. P. (2004) · Frontiers in bioscience · doi:10.2741/1465 · Cited by 38
Natural killer cell activation receptors in innate immunity to infection.
Yokoyama, W., & Scalzo, A. (2002) · Microbes and infection · doi:10.1016/s1286-4579(02)00034-5 · Cited by 46
Hu, J., Zhu, S., Xia, X., Zhang, L., Kleinerman, E. S., & Li, S. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-34 · Cited by 38
“NKG2D ligands are primarily present in tumor cells or infected cells but not in normal tissues [17,33,34].”
BackgroundInfluentialRetargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
Cappuzzello, E., Tosi, A., Zanovello, P., Sommaggio, R., & Rosato, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1199311 · Cited by 37
“Interestingly, the ligands for NKG2D appear to have an expression pattern relatively restricted to malignant tissues.(12,13)”
BackgroundAnimal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration
Yamaguchi, R., & Perkins, G. A. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1470722 · Cited by 42
“often express NKG2D ligands, attracting and activating NK cells.(39,40) Rapid growth of cancer cells inevitably causes a certain number of cells to die.”
BackgroundRadionuclide-labeled gold nanoparticles for nuclei-targeting internal radio-immunity therapy
Su, W., Chen, C., Wang, T., Li, X., Liu, Y., Wang, H., Zhao, S., Zuo, C., Sun, G., & Bu, W. (2019) · Materials Horizons · doi:10.1039/c9mh01725a · Cited by 37
Shah, D., Comba, A., Faisal, S. M., Kadiyala, P., Baker, G. J., Alghamri, M. S., Doherty, R., Zamler, D. B., Núñez, G., Castro, M. G., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1939601 · Cited by 41
“ligands which are expressed in stressed or transformed cells, has been shown to be a very important mechanism of NK cell recognition and rejection of tumor cells in general.(7,8) Therefore, we tested whether GL26-GAL1 gliomas would be rejected in NKG2D mice.”
BackgroundSchuster, C., Berger, A., Hoelzl, M. A., Putz, E. M., Frenzel, A., Simma, O., Moritz, N., Hoelbl‐Kovacic, A., Kovačic, B., Freissmuth, M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313098 · Cited by 43
Viral Interference with Antigen Presentation to CD8 + T Cells: Lessons from Cytomegalovirus
Pinto, A. K., & Hill, A. B. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.434 · Cited by 38
Cancer Immunoediting of the NK Group 2D Ligand H60a
O’Sullivan, T. E., Dunn, G. P., LaCoursiere, D. Y., Schreiber, R. D., & Bui, J. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100413 · Cited by 37
Making Sense of the Diverse Ligand Recognition by NKG2D
Radaev, S., Kattah, M. G., Zou, Z., Colonna, M., & Sun, P. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6279 · Cited by 43
Huang, M., Sun, R., Wei, H., & Tian, Z. (2012) · Hepatology · doi:10.1002/hep.25959 · Cited by 37
“Expression of NKG2D ligands renders target cells susceptible to NK cells cytolysis and induces interferon-c (IFN-c) production by NK cells.(1,7,8,10) It was reported that NKG2D was involved in NK cell– mediated allergic airway inflammation, and blocking antibody for NKG2D receptor delayed airway allergy.”
BackgroundOsterburg, A. R., Nelson, R. L., Yaniv, B. Z., Foot, R., Donica, W. R. F., Nashu, M. A., Liu, H., Wikenheiser‐Brokamp, K. A., Moss, J., Gupta, N., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87270 · Cited by 36
Kinoshita, N., Hiroi, T., Ohta, N., Fukuyama, S., Park, E. J., & Kiyono, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6187 · Cited by 36
“Together with our results, it may be possible that IL-15 regulates the expression of different NKR in a nonspecific and cumulative manner.”
BackgroundInfluentialImmunogenetics of the NKG2D ligand gene family
Kasahara, M., & Yoshida, S. (2012) · Immunogenetics · doi:10.1007/s00251-012-0638-9 · Cited by 37
“They were later shown to function as ligands for the NKG2D receptor (Cerwenka et al. 2000; Diefenbach et al. 2000).”
BackgroundDandekar, A. A., O’Malley, K. J., & Perlman, S. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9388-9396.2005 · Cited by 38
“Of note, H-60 is not expressed in C57BL/6 mice (15, 48).”
BackgroundNKG2D in Innate and Adaptive Immunity
Lanier, L. L. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-24180-9_7 · Cited by 39
Belting, L., Hömberg, N., Przewoznik, M., Brenner, C., Riedel, T., Flatley, A., Polić, B., Busch, D. H., Röcken, M., & Mocikat, R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445375 · Cited by 40
Kim, J.-Y., Bae, J., Lee, S.-H., Lee, E.-Y., Chung, B., Kim, S.-H., & Kang, C. (2008) · Journal of immunotherapy · doi:10.1097/cji.0b013e3181755deb · Cited by 34
“However, recent findings illustrated that NK cell activation via NKG2D receptor can occur despite the normal expression of MHC class I molecules on the target cells.(40,41) Stress-induced upregulation of NKG2D ligands in tumor cells may trigger an additional signal toward activation and induction of NK cell-mediated c…”
BackgroundBolanos, F. D., & Tripathy, S. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003046 · Cited by 33
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
Sauer, M., Schuldner, M., Hoffmann, N., Cetintas, A., Reiners, K. S., Shatnyeva, O., Hallek, M. J., Hansen, H. P., Gasser, S., & von Strandmann, E. P. (2016) · Oncogene · doi:10.1038/onc.2016.259 · Cited by 38
Human Natural Killer Receptors and Their Ligands
Biassoni, R., Bottino, C., Cantoni, C., & Moretta, A. (2001) · Current Protocols in Immunology · doi:10.1002/0471142735.im1410s46 · Cited by 39
“Interestingly, the murine NKG2D binds two distinct ligands, termed H60 and Rae1β; the latter is a GPI-linked molecule that shares a high degree of homology with human ULBPs (Nomura et al. , 1996; Malarkannan et al., 1998; Cerwenka et al., 2000; Diefenbach et al., 2000).”
BackgroundRegulation of Human DAP10 Gene Expression in NK and T Cells by Ap-1 Transcription Factors
Marusina, A. I., Burgess, S. J., Pathmanathan, I., Borrego, F., & Coligan, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.409 · Cited by 34
“Previous studies have shown that TCR-induced stimulation of CD8 T cells increases cell surface expression of murine NKG2D within 4 days (16, 54), which agrees with a reported increase in human DAP10 protein and mRNA levels by day 10 (37).”
BackgroundDirect Interaction of the Mouse Cytomegalovirus m152/gp40 Immunoevasin with RAE-1 Isoforms
Li, Z., Mans, J., Paskow, M. J., Brown, P. H., Schuck, P., Jonjić, S., Natarajan, K., & Margulies, D. H. (2010) · Biochemistry · doi:10.1021/bi902130j · Cited by 33
“Indeed, previous efforts in several labs have failed to demonstrate direct interaction by co-immunoprecipitation or immunoprecipitation and blotting (20,21,24).”
BackgroundNow you see it, now you don't!
Yokoyama, W. M. (2000) · Nature Immunology · doi:10.1038/77878 · Cited by 33
Mendoza, L. M., Villaflor, G., Eden, P. A., Roopenian, D. C., & Shastri, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4438 · Cited by 35
Self-citationBalint, E., Feng, E., Giles, E. C., Ritchie, T. M., Qian, A. S., Vahedi, F., Montemarano, A., Portillo, A. L., Monteiro, J. K., Trigatti, B. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44667-0 · Cited by 39
“YAC-1 cells are commonly used targets for mouse NK cell cytotoxicity assays and are known to express NKG2D ligands, but are typically resistant to T cell killing 53 .”
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer
Peipp, M., Klausz, K., Boje, A. S., Zeller, T., Zielonka, S., & Kellner, C. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac028 · Cited by 39
Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
Arnon, T. I., Markel, G., Bar-Ilan, A., Hanna, J. H., Fima, E., Benchetrit, F., Galili, R., Cerwenka, A., Benharroch, D., Sion‐Vardy, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002150 · Cited by 34
“Indeed, several stress inducible cellular proteins have been identified as ligands for the NKG2D receptor: the MHC class I chain related antigens (MICA and MICB) and the UL16 binding proteins (ULBP1-4) [10].”
BackgroundCellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Arina, A., Murillo, O., Dubrot, J., Azpilikueta, A., Alfaro, C., Perez‐Gracia, J. L., Bendandi, M., Palencia, B., Hervás‐Stubbs, S., & Melero, I. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.599 · Cited by 39
“NKG2D ligands have traditionally been considered to be expressed at low levels on the surface of most normal cells, and compelling evidence exists that they are often upregulated in tumors [52,53] or infected cells.”
BackgroundPoggi, A., Prevosto, C., Zancolli, M., Canevali, P., Musso, A., & Zocchi, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.007 · Cited by 31
Requirements for control of B‐cell lymphoma by NK cells
Brenner, C. D., King, S. B. S., Przewoznik, M., Wolters, I., Adam, C., Bornkamm, G. W., Busch, D. H., Röcken, M., & Mocikat, R. (2009) · European Journal of Immunology · doi:10.1002/eji.200939937 · Cited by 46
Awasthi, A., Samarakoon, A., Dai, X., Wen, R., Wang, D., & Malarkannan, S. (2008) · Genes and Immunity · doi:10.1038/gene.2008.45 · Cited by 32
Meyers, J. H., Ryu, A., Monney, L., Nguyen, K., Greenfield, E. A., Freeman, G. J., & Kuchroo, V. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5382 · Cited by 32
“Primers used for specific amplification of NKG2 family members are NKG2A5, NKG2A3 (9), NKG2C5, NKG2C/E3 (10), NKG2E5 (11), NKG2D5, and NKG2D3 (12).”
BackgroundRibeiro, C. H., Kramm, K., Gálvez‐Jirón, F., Pola-Véliz, V., BUSTAMANTE, M., Contreras, H. R., Sabag, A., Garrido‐Tapia, M., Hernández, C., ZÚÑIGA, R., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4510 · Cited by 33
“Since NK cells can efficiently recognize and kill tumors bearing NKG2D ligands (NKG2DLs) (13), the presence of these molecules on the cell surface potentially serves as ‘danger signals’ to alert the innate immune system to the existence of transformed cells, thus contributing to their elimination (14).”
BackgroundNatural killer cell receptors: Regulating innate immune responses to hematologic malignancy
Hsu, K. C., & Dupont, B. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.01.010 · Cited by 34
Infection-Induced Expansion of a MHC Class Ib-Dependent Intestinal Intraepithelial γδ T Cell Subset
Davies, A., López-Briones, S., Ong, H., O’Neil-Marshall, C., Lemonnier, F. A., Nagaraju, K., Metcalf, E. S., & Soloski, M. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6828 · Cited by 35
Maeda, M., Shadeo, A., MacFadyen, A. M., & Takei, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6115 · Cited by 32
Tian, W., Núñez, R., Cheng, S., Ding, Y., Tumang, J. R., Lyddane, C., Roman, C. A. J., & Liou, H. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.04.021 · Cited by 32
Piersma, S. J., Pak-Wittel, M. A., Lin, A., Plougastel-Douglas, B., & Yokoyama, W. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900718 · Cited by 31
“expression of m157 and NKG2D ligands (5, 16, 17).”
BackgroundWang, R., Natarajan, K., Revilleza, M. J., Boyd, L. F., Zhi, L., Zhao, H., Robinson, H. H., & Margulies, D. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214088109 · Cited by 31
Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in Northeastern Thais
Romphruk, A. V., Romphruk, A., Naruse, T. K., Raroengjai, S., Puapairoj, C., Inoko, H., & Leelayuwat, C. (2009) · Immunogenetics · doi:10.1007/s00251-009-0394-7 · Cited by 31
“Instead, the family of proteins encoded by the retinoic acid early transcript 1 (Rae1) and the minor histocompatibility antigen H60 gene, and the MULT1 molecule were identified as the ligands for mouse NKG2D (Carayannopoulos et al. 2002; Cerwenka et al. 2002; Diefenbach et al. 2000).”
BackgroundFusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
Ding, H., Yang, X., & Wei, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010177 · Cited by 33
Elimination In Vivo of Developing T Cells by Natural Killer Cells
Schott, E., Bonasio, R., & Ploegh, H. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030918 · Cited by 34
“Binding of H-60 to NKG2D was implicated in targeting of class I MHC–positive activated lymphocytes by NK cells in an in vitro model (55).”
BackgroundInfluentialRegulation of Natural Killer Cell Function
Makrigiannis, A. P., & Anderson, S. K. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.560 · Cited by 33
Cutting Edge: The Minor Histocompatibility Antigen H60 Peptide Interacts with Both H-2Kb and NKG2D
Cerwenka, A., O’Callaghan, C. A., Hamerman, J. A., Yadav, R., Ajayi, W. U., Roopenian, D. C., Joyce, S., & Lanier, L. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3131 · Cited by 31
“The H60 glycoprotein is a ligand for NKG2D, an activating NK cell receptor expressed by NK cells, CD8 T cells, and activated macro phages (14, 15).”
BackgroundCutting Edge: FcR-Like 5 on Innate B Cells Is Targeted by a Poxvirus MHC Class I-Like Immunoevasin
Campbell, J. A., Davis, R. S., Lilly, L. M., Fremont, D. H., French, A. R., & Carayannopoulos, L. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000240 · Cited by 30
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
Velardi, A., Ruggeri, L., Mancusi, A., Burchielli, E., Perruccio, K., Aversa, F., Martelli, M. F., & on behalf of the Immunobiology Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0136-1 · Cited by 33
Walsh, K. B., Lanier, L. L., & Lane, T. E. (2007) · Journal of Virology · doi:10.1128/jvi.02033-07 · Cited by 40
“The interaction between the NKG2D receptor and specific ligands results in enhanced effector functions by NK cells, including the secretion of IFN- and cytotoxic activity that augments the killing of NKG2D ligand-bearing target cells (14, 15, 20, 21, 57).”
Influence of Innate Immunity on Cancer Cell Stemness
Pastò, A., Consonni, F. M., & Sica, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093352 · Cited by 34
“release of nitric oxide (NO) and TNFα, which can be induced through NK2GD triggering [43].”
BackgroundPark, M.-J., Bae, J.-H., Chung, J. S., Kim, S.-H., & Kang, C. (2011) · Immunological Investigations · doi:10.3109/08820139.2010.551435 · Cited by 30
Phillips, L., Gould, E. A., Babu, H., Krams, S. M., Palmer, T. D., & Martinez, O. M. (2013) · Stem Cells · doi:10.1002/stem.1422 · Cited by 30
Chen, Y., Lin, W., Zhu, W., Lin, J., Zhou, Z., Huang, C., Chen, G., Shi, Y., Guo, Z., & Ye, Y. (2015) · Immunologic Research · doi:10.1007/s12026-015-8743-0 · Cited by 31
“As shown by blocking antibodies and transfection experiments, natural or induced expression of NKG2D ligands, such as MICA/B, markedly enhances the sensitivity of tumor cells to NK cells or CIK cells in vitro [19, 26–28].”
BackgroundThe balancing act: Inhibitory Ly49 regulate NKG2D-mediated NK cell functions
Malarkannan, S. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.04.002 · Cited by 33
“Eloquent studies by Raulet and Lanier laboratories have demonstrated that interaction of NKG2D with its cognate ligands can override the negative signals provided by inhibitory receptors [34,35].”
BackgroundCellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
Donini, C., Rotolo, R., Proment, A., Aglietta, M., Sangiolo, D., & Leuci, V. (2021) · Cells · doi:10.3390/cells10030543 · Cited by 29
Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection
Hartwig, S. M., Miller, A. M., & Varga, S. M. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2000751 · Cited by 33
Baba, T., Iwasaki, S., Maruoka, T., Suzuki, A., Tomaru, U., Ikeda, H., Yoshiki, T., Kasahara, M., & Ishizu, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2999 · Cited by 28
Imbalance of NKG2D and its inhibitory counterparts: How does tumor escape from innate immunity?
Zhang, C., Zhang, J., Wei, H., & Tian, Z. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.03.003 · Cited by 29
“Engagement of NKG2D on Mf with their ligands on target cells results in the secretion of nitric oxide and TNF by Mf [60–62].”
BackgroundEAE Tolerance Induction with Hsp70-Peptide Complexes Depends on H60 and NKG2D Activity
Gałązka, G., Jurewicz, A., Orłowski, W., Stasiołek, M., Brosnan, C. F., Raine, C. S., & Selmaj, K. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4503 · Cited by 28
“The known murine NKG2D ligands include five RAE-1 molecules (15), H60 (16, 17), and MULT-1 (18).”
BackgroundA battle for survival: immune control and immune evasion in murine γ-herpesvirus-68 infection
Stevenson, P. G., Boname, J. M., de Lima, B. D., & Efstathiou, S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01643-x · Cited by 28
Commentary: C‐type lectins on the macrophage cell surface – recent findings
Marshall, A. S. J., & Gordon, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200324641 · Cited by 31
Role of NK Cells and Invariant NKT Cells in Multiple Sclerosis
Sakuishi, K., Miyake, S., & Yamamura, T. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_11 · Cited by 32
“RAE-1 is also expressed on virus-infected cells (Backstrom et al. 2007), and binds to the stimulatory receptor expressed on NK cells, NKG2D (Diefenbach et al. 2000; Smyth et al. 2005).”
BackgroundEnhancing cytokine-induced killer cell therapy of multiple myeloma
Liu, C., Suksanpaisan, L., Chen, Y.-W., Russell, S. J., & Peng, K.-W. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.01.010 · Cited by 30
“010 include the MHC class I–related chain A and B (MICA and MICB) and the family of UL16-binding proteins (ULBP-1, 2, and 3) [8–10].”
BackgroundMCMV avoidance of recognition and control by NK cells
Brizić, I., Roviš, T. L., Krmpotić, A., & Jonjić, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0441-9 · Cited by 27
“H60 family of NKG2D ligands comprises three members: H60a, H60b, and H60c [15, 16].”
Graham, C. M., Christensen, J. R., & Thomas, D. B. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02563.x · Cited by 27
Stimulating natural killer cells to protect against cancer: recent developments
Gillgrass, A. E., & Ashkar, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.102 · Cited by 31
Continuous CD27 triggering in vivo strongly reduces NK cell numbers
Colvenaer, V. D., Taveirne, S., Hamann, J., de Bruin, A. M., Smedt, M. D., Taghon, T., Vandekerckhove, B., Plum, J. R., van Lier, R. A. W., & Leclercq, G. (2010) · European Journal of Immunology · doi:10.1002/eji.200939251 · Cited by 27
Current progress in γδ T-cell biology
Hao, J., Wu, X., Xia, S., Li, Z., Wen, T., Zhao, N., Wu, Z., Wang, P., Zhao, L., & Yin, Z. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.50 · Cited by 33
Mechanism of Human Natural Killer Cell Activation byHaemophilus ducreyi
Li, W., Janowicz, D. M., Fortney, K. R., Katz, B. P., & Spinola, S. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/600123 · Cited by 27
“For example, the triggering of the NK receptor NKG2D or ligation of the NK costimulatory molecule 2B4 promotes IFN-g production [22, 23].”
BackgroundInnate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function
Lee, S. H., Webb, J. R., & Vidal, S. M. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00032-1 · Cited by 27
Recognition of Self and Viral Ligands by NK Cell Receptors
Mariuzza, R. A., Singh, P., Karade, S. S., Shahid, S., & Sharma, V. K. (2025) · Immunological Reviews · doi:10.1111/imr.13435 · Cited by 27
Brodin, P., Lakshmikanth, T., Mehr, R., Johansson, M. H., Duru, A. D., Achour, A., Salmon‐Divon, M., Kärre, K., Höglund, P., & Johansson, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013174 · Cited by 27
“Thus, a target cell can become NK cell sensitive either by upregulation of ligands for activating NK cell receptors or by downregulation of MHC class I [4,5,6].”
BackgroundADAP is dispensable for NK cell development and function
Fostel, L. V., Dluzniewska, J., Shimizu, Y., Burbach, B. J., & Peterson, E. J. (2006) · International Immunology · doi:10.1093/intimm/dxl063 · Cited by 26
Gillard, G. O., Bivas‐Benita, M., Hovav, A., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/annotation/b29086ef-e08d-444c-8113-18a6dd429a7c · Cited by 27
Tabayoyong, W., Salas, J. G., Bonde, S., & Zavazava, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901807 · Cited by 25
Wai, L., Garcia, J. A., Martinez, O. M., & Krams, S. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002597 · Cited by 25
“NKG2D binds to MHC class I-related ligands, including stress-induced MICA/MICB and UL16-binding proteins in humans (3, 4), RAE-1 and H60 in mice (5), and RAE-1–like transcript in rats”
BackgroundChen, G. E., Wu, H., Ma, J., Chadban, S. J., & Sharland, A. F. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr234 · Cited by 26
“Ligation of NKG2D provides a co-stimulatory signal to enhance TCR-mediated antigen specific CD8(1) T cell activation, proliferation and granule exocytosis [12,29], and directly activates the effector functions of other leukocytes: NK cells release both granules and cytokines (IFN-c), while macrophages produce the infl…”
BackgroundGullion, D. S., Adamson, T. E., & Ms, W. (1983) · PubMed Central · Cited by 29
Regulation of porcine classical and nonclassical MHC class I expression
Tennant, L. M., Renard, C., Chardon, P., & Powell, P. P. (2007) · Immunogenetics · doi:10.1007/s00251-007-0206-x · Cited by 25
Poggi, A. D., & Zocchi, M. R. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.07.003 · Cited by 26
The Role of NK Cells and NK Cell Receptors inAutoimmune Disease
Jie, H.-B., & Sarvetnick, N. (2004) · Autoimmunity · doi:10.1080/0891693042000196174 · Cited by 25
“[53] Expression of the murine NKG2D ligands, H60 and Rae-1, is also induced in normal skin by carcinogens[54] and in embryonic cell lines by retinoic acid.”
BackgroundInfluentialParoxysmal nocturnal hemoglobinuria: Insights from recent advances in molecular biology1
Bessler, M., Schaefer, A., & Keller, P. (2001) · Transfusion Medicine Reviews · doi:10.1053/tmrv.2001.26958 · Cited by 25
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.